why choose us

First received: November 17, 2023

Clinical Trial: An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pulmonary Sarcoidosis

Study Type: INTERVENTIONAL


Official Title: A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement

Brief Summary: Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement

Read more